STADA Start Company Products Investor Relations Press Career German Faculty Login Peter Goldschmidt continues the Group's long-term growth as new CEO. Press release •••• Digitization Strategic portfolio expansion Latest Press Releases 09/18/2018 - 03.12 PM Press Release Voting results of the bondholders’ meeting concerning the STADA-Bond 2015/2022 09/12/2018 - 12.00 PM Press Release STADA invites the holders of the STADA Bond to participate in the bondholders‘ meeting and to vote in favor of the proposed resolutions More press releases go to archive Company STADA – a publicly traded, international company with a focus on the healthcare market. Learn more STADA-EURO-Bond 2015/2022 In this area you can find information on the invitation to the Bondholders‘ Meeting on September 18, 2018. Learn more STADA Worldwide STADA is represented worldwide in about 50 sales companies in more than 30 countries. Learn more STADA Generics What are generics? One of STADA's important business areas is the production and sales of inexpensive medicines that are generally known as generics. Learn more Products STADA Branded Products A strong brand with strong brands Learn more Financial Reports Annual Reports and Interim Reports Products Curazink® Grippostad® Hedrin® Hoggar® Ladival® Locastad® Magnetrans® Multilind® Mobilat® STADA Diagnostik All Products Follow us STADA on Twitter STADA on Facebook STADA on YouTube STADA on XING STADA on LinkedIn Company Contact Contact Investor Relations Contact Press Newsletter Jobs Your journey to us Disclaimer Privacy Policy Imprint German Version Contact STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Phone 06101 603-0 Fax 06101 603-259 E-Mail: info@stada.de STADA is a Member of discover